Semaglutide, a medication widely used for diabetes and weight loss, may offer another unexpected benefit -- it could help ...
Semaglutide is the active ingredient in three medications approved by the U.S. Food and Drug Administration (FDA): Ozempic, Rybelsus, and Wegovy. The first two are approved to treat type 2 ...
Semaglutide's role extends beyond diabetes, aiding weight loss and offering cardiovascular protection, with ongoing research ...
Researchers at the University of North Carolina found that a once-weekly injection of Ozempic could cut cravings at its ...
"They’re priced for profits, not patients.” That’s the critique from Hims & Hers Health’s buzzy — and controversial — Super ...
Is compounded semaglutide effective for weight loss? Here’s the short version: Compounded semaglutide isn’t approved by the ...
Wegovy (semaglutide ... drug, including details about its uses, see this Wegovy overview. Wegovy has a boxed warning. A boxed warning is the most serious warning from the Food and Drug ...
Rybelsus (semaglutide) is a brand-name oral tablet prescribed for type 2 diabetes. As with other drugs, Rybelsus can cause side effects, such as nausea, vomiting, and constipation. Read on to ...
22h
News Medical on MSNBlockbuster drug for diabetes and obesity could also help reduce alcohol intakeThe blockbuster drug semaglutide, better known as Ozempic for diabetes and Wegovy for obesity, could also help people cut down on their alcohol intake, according to new USC research.
Randomized, placebo-controlled trial finds that low-dose semaglutide reduces amount of alcohol consumption, alcohol cravings, and heavy drinking days. Reductions in cigarettes per day were also seen.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results